DFTX · Insider trading · 13F holders · Congress trades
Definium Therapeutics, Inc. (DFTX)
Who is buying and selling DFTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 0
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $3.0M
- Congress trades, 12 months
- 0
DFTX at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 5 DFTX insiders filed 6 sales worth $3.0M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
- No 13F filer reports DFTX among its 50 largest positions.
- No member of Congress has disclosed a trade in DFTX.
- DFTX last closed at $37.96 on Oct 29, 2026.
DFTX insider trading
Between Aug 1, 2026 and Oct 29, 2026, 5 DFTX insiders filed 6 sales worth $3.0M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Barrow Robert | Chief Executive Officer, Director | Sale10b5-1 | 31,550 | $36.57 | $1.2M | SEC |
| Sep 29, 2026 | Sullivan Mark | Chief Legal Officer | Sale10b5-1 | 14,051 | $36.57 | $514K | SEC |
| Sep 29, 2026 | Karlin Daniel | Chief Medical Officer, Director | Sale10b5-1 | 10,853 | $36.57 | $397K | SEC |
| Sep 29, 2026 | Roberts Brandi | Chief Financial Officer | Sale10b5-1 | 3,377 | $36.57 | $123K | SEC |
| Sep 29, 2026 | Wiley Matthew T. | Chief Commercial Officer | Sale10b5-1 | 3,097 | $36.57 | $113K | SEC |
| Sep 4, 2026 | Barrow Robert | Chief Executive Officer, Director | Sale10b5-1 | 19,023 | $37.94 | $722K | SEC |
Who owns DFTX? Hedge funds and superinvestors
No 13F filer reports DFTX among its 50 largest positions.
DFTX stock trades by members of Congress
No member of Congress has disclosed a trade in DFTX.
DFTX questions and answers
Are insiders buying DFTX stock?
Between Aug 1, 2026 and Oct 29, 2026, 5 DFTX insiders filed 6 sales worth $3.0M on SEC Form 4, and no open-market purchases; 6 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own DFTX?
No 13F filer reports DFTX among its 50 largest positions.
Has Congress traded DFTX?
No member of Congress has disclosed a trade in DFTX.
Cite or share this
Free to use with a link back. The data updates every filing day.